ARMISTICE CAPITAL, LLC

Position in NVO — Novo Nordisk A S

CIK 1601086 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$14,957,280

-$2,138,400 QoQ

Shares Held

312,000

-7.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#124

of 1,348 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARMISTICE CAPITAL, LLC holds $110,331,379 across 6 Drug Manufacturers - General names. NVO ranks #4 (13.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SNY	Sanofi	1,064,000	$45,390,240
2	GRFS	Grifols SA	2,936,000	$20,786,880
3	GSK	GSK plc	300,000	$15,726,000
4	NVO	Novo Nordisk A S This page	312,000	$14,957,280
5	BMY	Bristol Myers Squibb Co	233,790	$13,470,979
6	MDCX	Medicus Pharma Ltd.	60,600	$0

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,957,280	312,000	-7.1%	Shares	Sole	2026-08-14
2025-12-31	$17,095,680	336,000	-54.3%	Shares	Sole	2026-02-17
2025-09-30	$40,840,640	736,000	+581.5%	Shares	Sole	2025-11-17
2025-03-31	$7,499,520	108,000	-84.8%	Shares	Sole	2025-05-15
2024-12-31	$61,246,240	712,000	+26.0%	Shares	Sole	2025-02-14
2024-09-30	$67,274,550	565,000	+3.9%	Shares	Sole	2024-11-14
2024-06-30	$77,650,560	544,000	+36.0%	Shares	Sole	2024-08-14
2024-03-31	$51,360,000	400,000	+1.0%	Shares	Sole	2024-05-15
2023-12-31	$40,966,200	396,000	-9.2%	Shares	Sole	2024-02-13
2023-09-30	$39,649,840	436,000	+61.5%	Shares	Sole	2023-11-14
2023-06-30	$43,694,100	270,000	-7.5%	Shares	Sole	2023-08-14
2023-03-31	$46,468,880	292,000	-6.4%	Shares	Sole	2023-05-15
2022-12-31	$42,226,080	312,000	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.